|
|
Drugs for Hypoxia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 570)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Dopamine | approved | Phase 4, Phase 2, Phase 1 | 3836 | 51-61-6, 62-31-7 | 681 | (3H)-Dopamine .Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium 153C5321-5FEE-4B0B-8925-F388F0EEEBD1 2-(3,4-Dihydroxyphenyl)ethylamine 2-(3,4-dihydroxyphenyl)ethylamine 2-benzenediol 3,4-Dihydroxyphenethylamine 3,4-Dihydroxyphenethylamine hydrochloride 3,4-Dihydroxyphenylethylamine 3,4-dihydroxyphenethylamine 3-Hydroxtyramine 3-Hydroxytyramine 3-Hydroxytyramine Hydrobromide 3-Hydroxytyramine hydrochloride 4-(2-Aminoethyl)-1, 4-(2-Aminoethyl)-1,2-benzenediol 4-(2-Aminoethyl)-1,2-bezenediol 4-(2-Aminoethyl)-Pyrocatechol 4-(2-Aminoethyl)benzene-1,2-diol 4-(2-Aminoethyl)catechol 4-(2-Aminoethyl)pyrocatechol 4-(2-Aminoethyl)pyrocatechol hydrochloride 4-(2-aminoethyl)-pyrocatechol 50444-17-2 51-61-6 62-31-7 (HYDROCHLORIDE) AC1L19S5 AC1Q54AX AC1Q54AY AKOS003790978 ASL 279 BIDD:ER0506 BPBio1_001123 BSPBio_001932 Biomol-NT_000001 C03758 CHEBI:18243 CHEMBL59 CID681 D07870 DB00988 Deoxyepinephrine DivK1c_000780 Dopamin Dopamina Dopamina [INN-Spanish] Dopamine Dopamine (INN) Dopamine (USAN)(*hydrochloride*) Dopamine [INN:BAN] Dopaminum Dopaminum [INN-Latin] Dopastat Dophamine Dynatra EINECS 200-110-0 HSDB 3068 Hydroxytyramin Hydroxytyramine IDI1_000780 IP 498 Intropin Intropin [*hydrochloride*] KBio1_000780 | KBio2_001492 KBio2_002388 KBio2_002484 KBio2_004060 KBio2_004956 KBio2_005052 KBio2_006628 KBio2_007524 KBio2_007620 KBio3_001152 KBio3_002867 KBio3_002962 KBioGR_001129 KBioGR_002388 KBioGR_002484 KBioSS_001492 KBioSS_002393 KBioSS_002491 KW-3-060 L-DOPAMINE L000232 LDP LS-159 Lopac-H-8502 Lopac0_000586 Medopa (TN) MolPort-001-641-000 NCGC00015519-01 NCGC00015519-08 NCGC00096050-01 NCGC00096050-02 NCGC00096050-03 NCGC00096050-04 NCGC00096050-05 NINDS_000780 NSC 173182 NSC169105 NSC173182 Oprea1_088821 Oxytyramine Pyrocatechol, 4-(2-aminoethyl)- (8CI) Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride Revimine Revivan SPBio_001205 SPECTRUM1505155 ST048774 STK301601 Spectrum2_001023 Spectrum3_000406 Spectrum4_000525 Spectrum5_000945 Spectrum_001012 UNII-VTD58H1Z2X UPCMLD0ENAT5885989:001 a-(3,4-Dihydroxyphenyl)-b-aminoethane alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane cMAP_000036 cMAP_000065 dopamine hydroxytyramine intropin m-Hydroxytyramine hydrochloride nchembio.105-comp9 nchembio.107-comp4 nchembio.284-comp1 nchembio.78-comp16 nchembio.89-comp3 nchembio705-8 nchembio801-comp8 |
| | 2 | | Epinephrine | approved, vet_approved | Phase 4, Phase 2, Phase 3 | 985 | 51-43-4 | 5816 | (-)-(R)-Epinephrine (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol (-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol (-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol (-)-Adrenalin (-)-Adrenaline (-)-Epinephrine (-)-R-Epinephrine (R)-(-)-Adnephrine (R)-(-)-Adrenaline (R)-(-)-Epinephrine (R)-(-)-Epirenamine (R)-(−)-adrenaline (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol (R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol (R)-Adrenaline (R)-Epinephrine (−)-adrenaline 02252_FLUKA 1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol 1-Adrenalin 1-Epinephrine 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol 4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol 51-43-4 51-43-4 (FREE BASE) 51028-73-0 A0173 AC-13188 AC1L1L7B ADR ADRENALINE ADROP AI3-19015 Adnephrine Adrenal Adrenalin Adrenalin (TN) Adrenalin in Oil Adrenalin-Medihaler Adrenalina Adrenalina [DCIT] Adrenaline Adrenaline (JP15) Adrenaline/Epinephrine Adrenalinum Adrenamine Adrenan Adrenapax Adrenasol Adrenatrate Adrenine Adrenodis Adrenohorma Adrenosan Adrenutol Adrin Adrine Ana-Guard Ana-Kit Antiasthmatique Asmatane Mist Asthma meter mist Asthma-nefrin Asthmahaler Mist Asthmanefrin Astmahalin Astminhal BIDD:GT0119 Balmadren Bernarenin Biorenine Bosmin Brevirenin Bronkaid Bronkaid Mist Bronkaid Suspension Mist Bupivacaine Hcl and Epinephrine C00788 CCRIS 4812 CHEBI:28918 CHEMBL679 CID5816 Chelafrin Citanest Forte Corisol D-Epifrin D-Epinephrine D00095 DB00668 Drenamist Dylephrin Dyspne-Inhal E4250_SIGMA EINECS 200-098-7 EPI E Z PEN JR EPIPEN E Z PEN EPIPEN JR Epi EZ Pen Jr Epifrin Epiglaufrin Epinefrin Epinefrin [Czech] Epinefrina Epinefrina [INN-Spanish] Epinephran Epinephrin Epinephrine Epinephrine (USP) Epinephrine (USP/INN) Epinephrine [USAN:INN:JAN] Epinephrine hydrochloride Epinephrinum Epinephrinum [INN-Latin] Epipen Epipen (TN) Epipen Auto-Injector Epipen EZ Pen Epipen Jr. Epipen Jr. Auto-Injector Epirenamine Epirenan Epirenin Epitrate Eppy Esphygmogenina Exadrin | Glaucon Glaucosan Glauposine Glycirenan HSCI1_000215 HSDB 4289 Haemostasin Haemostatin Hektalin Hemisine Hemostasin Hemostatin Hypernephrin Hyporenin IOP Intranefrin Iontocaine Isoptoepinal Kidoline L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol L-Adrenaline L-Adrenaline Base L-Epinehphrine L-Epinephrine L-Epirenamine L-Methylaminoethanolcatechol L-epinephrine LS-156 Levo-Methylaminoethanolcatechol Levoadrenaline Levoepinephrine Levorenen Levorenin Levorenine Levoreninum Lopac-E-4642 Lyodrin Lyophrin Medihaler-Epi Metanephrin Methylaminoethanolcatechol Methylarterenol Micronefrin Micronephrine MolPort-002-051-368 Mucidrina Myosthenine Mytrate NCGC00015417-01 NCGC00142615-01 NCGC00142615-03 NCGC00142615-04 NCGC00142615-05 NCGC00142615-06 NCGC00142615-07 NSC 62786 NSC62786 Nephridine Nieraline PDSP1_001120 PDSP2_001104 Paranephrin Primatene Primatene Mist R-(-)-Epinephrine R-Adrenaline RCRA waste no. P042 Racemic Epinephrine Racepinephrine Rcra waste number P042 Renagladin Renaglandin Renaglandulin Renaleptine Renalina Renoform Renostypricin Renostypticin Renostyptin SMP1_000227 ST069368 SUS-PHRINE SULFITE-FREE Scurenaline Septocaine Simplene Sindrenina Soladren Sphygmogenin Stryptirenal Styptirenal Supracapsulin Supradin Supranefran Supranephrane Supranephrine Supranol Suprarenaline Suprarenin Suprel Surenine Surrenine Sus-Phrine Sus-phrine Susphrine Sympathin I Takamina Takamine Tokamina Tonogen Twinject Twinject 0.15 Twinject 0.3 Twinject 0.30 UNII-YKH834O4BH Vaponefrin Vasoconstrictine Vasoconstrictor Vasodrine Vasoton Vasotonin adrenaline bmse000316 d-Adrenaline epinephrine l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol l-Adrenalin l-Adrenaline l-Epinephine l-Epinephrine (synthetic) l-Epirenamine l-Methylaminoethanolcatechol levoepinephrine nchembio747-comp9 |
| | 3 | | Sevoflurane | approved, vet_approved | Phase 4 | 508 | 28523-86-6 | 5206 | 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane 28523-86-6 AC-15484 AC1L1JU0 BRN 2041023 Bax 3084 C009250 C07520 C4H3F7O CHEBI:9130 CHEMBL1200694 CID5206 D00547 DB01236 F0691 Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether I14-13357 LS-67851 MR6S4 | MR_6S4 MolPort-001-775-746 NCGC00167421-01 PC4681 Sevofluran Sevoflurane Sevoflurane (JAN/USAN/INN) Sevoflurane [USAN:INN:BAN:JAN] Sevoflurano Sevoflurano [INN-Spanish] Sevofluranum Sevofluranum [INN-Latin] Sevofrane Sevorane Sojourn UNII-38LVP0K73A Ultane Ultane (TN) ZINC01530810 fluoromethyl hexafluoroisopropyl ether fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether sevoflurane |
| | 4 | | Propofol | approved, investigational, vet_approved | Phase 4 | 1082 | 2078-54-8 | 4943 | 2, 6-Diisopropylphenol 2,6 Diisopropylphenol 2,6-Bis(1-methylethyl)phenol 2,6-Bis(Isopropyl)-phenol 2,6-DIISOPROPYLPHENOL 2,6-Diisopropyl phenol 2,6-Diisopropylphenol 2,6-bis(1-methylethyl)-phenol 2,6-di(propan-2-yl)phenol 2078-54-8 28449-97-0 4-06-00-03435 (Beilstein Handbook Reference) 50356-15-5 AB00513968 AC-2038 AC1L1J9Y AC1Q1OUI AI3-26295 AM-149 Abbott Brand of Propofol Alpha Brand of Propofol Ampofol Aquafol Astra Brand of Propofol AstraZeneca Brand of Propofol BIDD:GT0436 BPBio1_000950 BPBio1_000969 BRD-K82255054-001-03-5 BRN 1866484 BSPBio_000862 Biomol-NT_000248 Braun Brand of Propofol C07523 C12H18O CAS-2078-54-8 CCRIS 9000 CHEBI:44915 CHEMBL526 CID4943 CPD-11437 CPD000059151 Curamed Brand of Propofol D00549 D015742 D0617 D126608 D126608_ALDRICH DB00818 DDS-04F Diisopropylphenol Dipravan Diprivan Diprivan (TN) Diprivan Injectable emulsion Disoprivan Disoprofol EINECS 218-206-6 EU-0100437 Fresenius Brand of Propofol Fresenius Kabi Brand of Propofol Fresofol HMS1570L04 HMS2089O21 HMS2094E17 | HSDB 7123 ICI 35,868 ICI 35868 ICI-35,868 ICI-35868 ICI35,868 ICI35868 InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H Ivofol Jsp004266 Juste Brand of Propofol LS-996 Lopac-D126608 Lopac0_000437 MLS001066348 MLS001335999 MLS002454360 MolPort-001-794-517 NCGC00015389-01 NCGC00015389-02 NCGC00015389-04 NCGC00015389-09 NCGC00091538-01 NCGC00091538-02 NCGC00091538-03 NCGC00091538-04 NCGC00091538-05 NCGC00091538-06 NSC 5105 NSC5105 PFL Parnell Brand of Propofol Pisa Brand of Propofol Prestwick0_000931 Prestwick1_000931 Prestwick2_000931 Prestwick3_000931 Propofol Propofol (JAN/USAN/INN) Propofol Abbott Propofol Fresenius Propofol IDD-D Propofol MCT Propofol Rovi Propofol [USAN:INN:BAN] Propofol(2,6-Diisopropylphenol) Propofol-Lipuro Propofolum Propofolum [Latin] Rapinovet Recofol Rovi Brand of Propofol S01-0189 SAM002264610 SMR000059151 SPBio_003031 SPECTRUM1505022 ST50405911 Schering Brand of Propofol UNII-YI7VU623SF W505102_ALDRICH ZD-0859 ZINC00968303 Zeneca Brand of Propofol ghl.PD_Mitscher_leg0.558 nchembio.552-comp7 propofol |
| | 5 | | Adenosine | approved, investigational | Phase 4, Phase 1, Phase 2 | 419 | 58-61-7 | 60961 | (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose 1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose 1odi 2fqy 2gl0 30143-02-3 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside 46946-45-6 46969-16-8 58-61-7 6-Amino-9-.beta.-ribofuranosyl-9H-purine 6-Amino-9-beta-D-ribofuranosyl-9H-purine 6-Amino-9beta-D-ribofuranosyl-9H-purine 6-Amino-9beta-delta-ribofuranosyl-9H-purine 9-(beta-D-Arabinofuranosyl)adenine 9-beta-D-Arabinofuranosyladenine 9-beta-D-Ribofuranosidoadenine 9-beta-D-Ribofuranosyl-9H-purin-6-amine 9-beta-D-Ribofuranosyladenine 9-beta-delta-Arabinofuranosyladenine 9-beta-delta-Ribofuranosidoadenine 9-beta-delta-Ribofuranosyl-9H-purin-6-amine 9-beta-delta-Ribofuranosyladenine 9beta-D-Ribofuranosyladenine 9beta-D-ribofuranosyl-9H-Purin-6-amine 9beta-delta-Ribofuranosyladenine 9beta-delta-ribofuranosyl-9H-Purin-6-amine A0152 A4036_SIGMA A9251_SIGMA AC1L1U8O AC1Q1ID3 AC1Q52XU ADN AI3-52413 Ade-Rib Ade-rib Adenin riboside Adenine 9-beta-D-arabinofuranoside Adenine deoxyribonucleoside Adenine nucleoside Adenine riboside Adenine-9-beta-D-ribofuranoside Adenine-9beta-D-Ribofuranoside Adenine-9beta-delta-Ribofuranoside Adenocard Adenocard (TN) Adenocard, Adenosine Adenocor Adenoscan Adenoscan (TN) Adenosin Adenosin [German] Adenosina Adenosine (JAN/USP) Adenosine [USAN:BAN] Adenosine, homopolymer Adenosinum Adensoine Adenyldeoxyriboside Ado Adénosine BB_NC-0565 BSPBio_001796 Bio1_000437 | Bio1_000926 Bio1_001415 Boniton C00212 CCRIS 2557 CHEBI:16335 CHEMBL477 CID60961 Caswell No. 010B D000241 D00045 DB00640 Deoxyadenosine Desoxyadenosine EA6C60C2-6AFB-4264-A2F0-541373DB950E EINECS 200-389-9 FT-0082881 HMS1920A13 HMS2091G13 KBio3_001296 LS-15085 MEDR-640 MLS000069638 MLS002153227 MolPort-001-838-229 Myocol NCGC00023673-03 NCGC00023673-04 NCGC00023673-05 NCGC00023673-06 NCGC00023673-07 NSC 627048 NSC 7652 NSC627048 NSC7652 Nucleocardyl Pallacor Polyadenosine Polyriboadenosine S1647_Selleck SDCCGMLS-0003108.P003 SMR000058216 SPBio_001194 SPECTRUM1500107 SR 96225 SR-96225 SUN-Y4001 Sandesin Spectrum2_001257 Spectrum3_000288 TL8003749 UNII-K72T3FS567 USAF CB-10 V0098 Vidarabine ZINC02169830 adenine-D-ribose adenosine b-D-Adenosine beta-Adenosine beta-D-Adenosine beta-D-Ribofuranoside, adenine-9 beta-delta-Adenosine bmse000061 nchembio.143-comp9 nchembio.186-comp109 nchembio.2007.56-comp13 nchembio.64-comp4 nchembio706-5 |
| | 6 | | Bromhexine | approved | Phase 4 | 2 | 3572-43-8 | | 3,5-Dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine Bromexina Bromhexina | Bromhexinum Fluibron N-Cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amine Tauglicolo | |
| | 7 | | Budesonide | approved | Phase 4, Phase 1 | 432 | 51333-22-3 | 63006, 5281004 | (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one (R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde (RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde (S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione 16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione 16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione 16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione 51333-22-3 AC-4697 AC1L1DQE AC1L1Y6Y AC1L22VC AC1MHWI7 B 7777 B7777_SIGMA BPBio1_000523 BRD-A34299591-001-03-4 BRD-A82238138-001-01-7 BSPBio_000475 BSPBio_002160 Bidien Bio-0010 Budecort Inhaler Budenofalk Budeson Budesonide (JAN/USAN/INN) Budesonide Easyhaler Budesonide MMX Budesonide [USAN:INN:BAN:JAN] Budesonido Budesonido [INN-Spanish] Budesonidum Budesonidum [INN-Latin] Budiair Budicort C25H34O6 CCRIS 5230 CHEBI:3207 CHEBI:656601 CHEMBL1370 CID2462 CID3033890 CID40000 CID5281004 CID63006 CPD000058337 Cortivent D00246 DB01222 Desowen Dexbudesonide Dexbudesonide [INN] DivK1c_000475 EINECS 257-139-7 EINECS 257-160-1 EINECS 257-161-7 EU-0100174 Entocort Entocort EC Entocort EC (TN) Giona Easyhaler HMS1569H17 HMS1921I22 HMS2094I13 HMS501H17 Horacort | IDI1_000475 Inflammide KBio1_000475 KBio3_001660 KBioGR_001361 LS-187734 LS-7235 Lopac0_000174 MAP-0010 MLS000028507 MLS001077323 MLS002207112 Micronyl Miflonide MolPort-002-529-265 MolPort-003-666-332 MolPort-003-986-909 NCGC00015165-03 NCGC00021318-03 NCGC00021318-06 NCGC00089747-02 NCGC00089747-03 NCGC00089747-04 NCGC00178789-01 NINDS_000475 Noex Preferid Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione Prestwick0_000518 Prestwick1_000518 Prestwick2_000518 Prestwick3_000518 Prestwick_840 Pulmaxan Pulmaxan turbohaler Pulmicort Pulmicort (TN) Pulmicort Flexhaler Pulmicort Nebuamp Pulmicort Respules Pulmicort Topinasal Pulmicort Turbuhaler Pulmicort turbuhaler Respules Rhinocort Rhinocort Aqua Rhinocort Turbuhaler Rhinocort alpha Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide Rhinosol S 1320 S-1320 S1286_Selleck SAM002699898 SMR000058337 SPBio_000586 SPBio_002396 SPECTRUM1500813 ST51039033 Spectrum2_000623 Spectrum3_000620 Spectrum4_000821 Spectrum5_001738 Spirocort TL8003397 Tridesilon UDB UNII-168L5HT37P UNII-2HI1006KPH UNII-Q3OKS62Q6X Unit dose budesonide ZINC03938751 ZINC04097286 budesonide | |
| | 8 | | Valproic Acid | approved, investigational | Phase 4 | 327 | 99-66-1 | 3121 | (N-C3H7)2CHCOOH (S)-2-propyl-4-pentanoate (S)-2-propyl-4-pentanoic acid 2 PP (base) 2-N-Propyl-N-valeric acid 2-Propyl-Pentanoate 2-Propyl-Pentanoic acid 2-Propylpentanoate 2-Propylpentanoic Acid 2-Propylpentanoic acid 2-Propylvaleric Acid 2-Propylvaleric acid 2-n-Propyl-n-valeric acid 2-n-propyl-n-valeric acid 2-propyl-pentanoic acid 2-propylvaleric acid 4-Heptanecarboxylic acid 4-heptanecarboxylic acid 76584-70-8 (hydrochloride salt (2:1)) 99-66-1 AC1L1F7T AC1Q2ULA AI3-10500 APO-divalproex Abbott 44090 Acide valproique Acide valproique [INN-French] Acide valproique [inn-french] Acido valproico Acido valproico [INN-Spanish] Acido valproico [inn-spanish] Acidum valproicum Acidum valproicum [INN-Latin] Acidum valproicum [inn-latin] Alti-Valproic Alti-valproic Apo-valproic Apo-valproic syrup Avugane BIDD:GT0858 BRN 1750447 Baceca C07185 CHEBI:39867 CHEMBL109 CID3121 CPD000499581 Convulex Convulsofin D00399 DB00313 DOM-divalproex DOM-valproic DOM-valproic acid E.C. DPA Delepsine Depacon Depakene Depakene (TN) Depakin Depakin chrono Depakine Depakine chrono Depakote Depakote (TM) Deproic Di-N-propylacetic acid Di-N-propylessigsaure Di-N-propylessigsaure [german] Di-n-propylacetic acid Di-n-propylessigsaeure Di-n-propylessigsaure Di-n-propylessigsaure [German] Di-n-propylessigsäure Dipropyl Acetate Dipropylacetate Dipropylacetic acid DivK1c_000273 Divalproex Dom-Valproic Dom-valproate Dom-valproic acid Dom-valproic acid syrup EINECS 202-777-3 Epiject I.V. Epilex Epilim Epival Epival er Ergenyl G2M-777 Gen-divalproex HMS2089J06 HSDB 3582 I04-0211 InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10) KBio1_000273 KBio2_001001 KBio2_002277 KBio2_003569 KBio2_004845 | KBio2_006137 KBio2_007413 KBio3_002626 KBio3_002757 KBioGR_000871 KBioGR_002277 KBioSS_001001 KBioSS_002278 Kyselina 2-propylvalerova Kyselina 2-propylvalerova [Czech] LS-161170 LS-2068 MLS001076682 MLS001335927 MLS001335928 MLS002415770 Med Valproic Med valproic MolPort-001-791-895 Mylproin Myproate Myproic Acid Myproic acid N-DPA N-Dipropylacetic acid NCGC00091149-01 NCGC00091149-02 NCGC00091149-03 NCGC00091149-04 NINDS_000273 NSC 93819 NSC93819 Novo-Valproic Novo-Valproic - ECC Novo-divalproex Novo-valproic Novo-valproic soft gel cap Nu-Valproic Nu-valproic P0823 P6273_SIGMA PEAC PHL-valproate PHL-valproic acid PHL-valproic acid E.C. PMS-Divalproex PMS-Valproic Acid PMS-valproate PMS-valproic acid PMS-valproic acid E.C. Penta-Valproic Penta-valproic Propylvaleric acid Ratio-Valproic - ECC S(-)-4-En-valproate S(-)-4-En-valproic acid S-2-N-Propyl-4-pentenoate S-2-N-Propyl-4-pentenoic acid SAM002564230 SBB065764 SMR000499581 SPBio_000912 Sandoz valproic Savicol Semisodium Valproate Sodium hydrogen divalproate Spectrum2_000946 Spectrum3_001733 Spectrum4_000376 Spectrum_000521 Sprinkle Stavzor UNII-614OI1Z5WI VALPROIC ACID VPA Valcote Valparin Valproate Valproate semisodique [French] Valproate semisodium Valproato semisodico [Spanish] Valproatum seminatricum [Latin] Valproic Acid, Sodium Salt (2:1) Valproic acid Valproic acid (USP) Valproic acid USP Valproic acid USP24 Valproic acid [USAN:INN:BAN] Valproic acid [usan:ban:inn] Valproinsaeure Valproinsäure Vupral WLN: QVY3 & 3 acide valproïque acidum valproicum di-n-propylacetic acid n-DPA n-Dipropylacetic acid nchembio.79-comp4 nchembio815-comp21 valproate valproic acid ácido valproico |
| | 9 | | Levodopa | approved | Phase 4 | 402 | 59-92-7 | 6047 | (-)-(3,4-Dihydroxyphenyl)alanine (-)-3-(3,4-Dihydroxyphenyl)-L-alanine (-)-3-(3,4-dihydroxyphenyl)-L-alanine (-)-Dopa (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid (−)-3-(3,4-dihydroxyphenyl)-L-alanine (−)-dopa .Beta.-(3, 4-Dihydroxyphenyl)alanine .Beta.-(3,4-Dihydroxyphenyl)-L-alanine 1E83F927-C221-46AA-B90A-81B33C5F3868 2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid 23734-74-9 25525-15-9 3, 4-Dihydroxy-L-phenylalanine 3, 4-Dihydroxyphenylalanine 3,4-DIHYDROXYPHENYLALANINE 3,4-Dihydroxy-L-phenylalanine 3,4-Dihydroxyphenyl-L-alanine 3,4-Dihydroxyphenylalanine 3,4-Dihydroxyphenylalanine (VAN) 3,4-dihydroxy-L-phenylalanine 3,4-dihydroxyphenylalanine 3-(3,4-Dihydroxypheny 3-(3,4-Dihydroxyphenyl)-L-alanine 3-Hydroxy-L-tyrosine 34241-25-3 37830_FLUKA 587-45-1 59-92-7 72572-99-7 72573-00-3 88250-23-1 90638-38-3 AC-11686 AC1L1LOR AC1Q4U7F BIDD:GT0158 BPBio1_000059 BSPBio_000053 BSPBio_002354 Bendopa Bio-0575 Biodopa Brocadopa C00355 C9H11NO4 CAS-59-92-7 CCRIS 3766 CHEBI:15765 CHEMBL1009 CID6047 Cerepap Cidandopa D 9628 D00059 D0600 D9628 D9628_SIGMA DAH DB01235 DOPA Deadopa Dihydroxy-L-phenylalanine Dihydroxyphenylalanine DivK1c_000452 Dopa Dopaflex Dopaidan Dopal Dopal-Fher Dopal-fher Dopalina Dopar Dopar (TN) Doparkine Doparl Dopasol Dopaston Dopaston SE Dopastone Dopastral Dopicar Doprin EINECS 200-445-2 EU-0100454 Eldopal Eldopar Eldopatec Eurodopa HMS1568C15 HMS1922J14 HMS2090O08 HMS2093N04 HMS501G14 HSDB 3348 Helfo DOPA | Helfo-Dopa Helfo-dopa IDI1_000452 IV Levodopa InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14 Insulamina KBio1_000452 KBio2_000934 KBio2_003502 KBio2_006070 KBioGR_001177 KBioSS_000934 L Dopa L(-)-Dopa L-(-)-Dopa L-(3, 4-Dihydroxyphenyl)-.alpha.-alani L-(3, 4-Dihydroxyphenyl)alanine L-(o-Dihydroxyphenyl)alanine L-.Beta.-(3,4-Dihydroxyphenyl)alanine L-3,4-Dihydroxyphenylalanine L-3,4-dihydroxyphenylalanine L-3-(3,4-Dihydroxyphenyl)-Alanine L-3-(3,4-Dihydroxyphenyl)alanine L-3-Hydroxytyrosine L-4-5-Dihydroxyphenylalanine L-DOPA L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa L-Dihydroxyphenylalanine L-Dopa L-O-Dihydroxyphenylalanine L-b-(3,4-Dihydroxyphenyl)-a-alanine L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine L-beta-(3,4-Dihydroxyphenyl)alanine L-o-Hydroxytyrosine LS-255 Laradopa Larodopa Ledopa Levedopa Levodopa Levodopa (JP15/USP) Levodopa (JP15/USP/INN) Levodopa [USAN:INN:BAN:JAN] Levodopum Levodopum [INN-Latin] Levopa Lopac-D-9628 Lopac0_000454 MLS000028514 Maipedopa MolPort-000-856-937 NCGC00015384-01 NCGC00016270-01 NCGC00016270-06 NCGC00093869-04 NINDS_000452 NSC 118381 NSC118381 PDSP1_001541 PDSP2_001525 Parda Pardopa Prestwick0_000017 Prestwick1_000017 Prestwick2_000017 Prestwick3_000017 Prestwick_185 Prodopa Ro 4-6316 S1726_Selleck SDCCGMLS-0066924.P001 SMR000058312 SPBio_000391 SPBio_001974 SPECTRUM2300205 Sobiodopa Spectrum2_000496 Spectrum4_000539 Spectrum5_001899 Spectrum_000454 Syndopa UNII-46627O600J Veldopa Weldopa b-(3,4-Dihydroxyphenyl)-L-alanine b-(3,4-Dihydroxyphenyl)-a-L-alanine b-(3,4-Dihydroxyphenyl)alanine beta-(3,4-Dihydroxyphenyl)-L-alanine beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine beta-(3,4-Dihydroxyphenyl)-alpha-alanine beta-(3,4-Dihydroxyphenyl)alanine bmse000322 component of Sinemet l)-L-alanine nchembio.2007.55-comp26 nchembio.89-comp9 ne β-(3,4-dihydroxyphenyl)alanine | |
| | 10 | | Metformin | approved | Phase 4, Phase 2 | 1803 | 657-24-9 | 14219, 4091 | 1,1-Dimethyl biguanide 1,1-Dimethylbiguanide 3-(diaminomethylidene)-1,1-dimethylguanidine 657-24-9 AC1L1HE4 AKOS000121065 Apo-Metformin BIDD:GT0697 BPBio1_000009 BRD-K79602928-003-04-1 BSPBio_000007 BSPBio_002314 C07151 C4H11N5 CAS-1115-70-4 CCRIS 9321 CHEBI:6801 CHEMBL1431 CID4091 D04966 DB00331 DMGG Diabetosan Diabex Dimethylbiguanid Dimethylbiguanide Dimethylbiguanidine Dimethyldiguanide Dimethylguanylguanidine EINECS 211-517-8 Fluamine Flumamine Fortamet Gen-Metformin Glifage Gliguanid Glucophage Glucophage XR Glumetza Glycon HMS2089D19 HSCI1_000295 Haurymelin Haurymellin Islotin KBio2_002310 KBio2_004878 KBio2_007446 KBio3_002790 KBioGR_002310 | KBioSS_002312 LA-6023 LS-43899 Melbin Metformin Metformin (USAN/INN) Metformin HCL Metformin [USAN:INN:BAN] Metformina Metformina [DCIT] Metformina [Spanish] Metformine Metformine [INN-French] Metformine pamoate Metforminum Metforminum [INN-Latin] Metiguanide MolPort-002-929-560 MolPort-004-288-389 MolPort-005-767-418 Mylan-Metformin N,N-Dimethylbiguanide N,N-Dimethyldiguanide N,N-Dimethylimidodicarbonimidic diamide N,N-dimethylimidodicarbonimidic diamide N1,N1-Dimethylbiguanide NCGC00016564-01 NCGC00016564-02 NCGC00016564-03 NNDG Novo-Metformin Nu-Metformin PMS-Metformin Prestwick0_000004 Prestwick1_000004 Prestwick2_000004 Prestwick3_000004 Ran-Metformin Ratio-Metformin Riomet S2483_Selleck SPBio_001928 STK011633 Sandoz Metformin Siofor T5895664 Teva-Metformin UNII-9100L32L2N ZINC12859773 cMAP_000016 metformin metformin hydrochloride |
| | 11 | | Acetylcysteine | approved, investigational | Phase 4, Early Phase 1 | 330 | 616-91-1 | 12035 | (2R)-2-acetylamino-3-sulfanylpropanoic acid (R)-2-acetylamino-3-mercaptopropanoic acid (R)-mercapturic acid 2-Acetylamino-3-mercapto-propionate 2-Acetylamino-3-mercapto-propionic acid ACC Acetadote Acetilcisteina Acetylcysteine Acetylcysteinum Fluimicil Infantil Fluimucetin Fluimucil Flumucetin Fluprowit | L-Acetylcysteine L-acetylcysteine L-α-acetamido-β-mercaptopropionic acid Lysox Mercapturic acid Mucolysin Mucomyst N-Acety-L-Cysteine N-Acetyl-3-mercaptoalanine N-Acetyl-L-(+)-cysteine N-Acetylcysteine N-acetyl-L-(+)-cysteine N-acetyl-L-cysteine N-acetylcysteine NAC Parvolex Sodium 2-acetamido-3-mercaptopropionate |
| | 12 | | Clonazepam | approved, illicit | Phase 4 | 32 | 1622-61-3 | 2802 | 1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one 1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one 1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one 106955-87-7 1622-61-3 5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one 5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one 5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one 5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one 5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one 5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one 5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one 5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one 5-24-04-00351 (Beilstein Handbook Reference) 7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one AC-15733 AC1L1EI2 Alti-Clonazepam Antelepsin Antilepsin BAS 00308658 BIDD:PXR0144 BRN 0759557 C1277_SIGMA C15H10ClN3O3 CHEBI:3756 CHEMBL452 CID2802 CLONAZEPAM Chlonazepam Cloazepam Clonazepam (JP15/USP/INN) Clonazepam [USAN:INN:BAN:JAN] Clonazepamum Clonazepamum [INN-Latin] Clonex Clonopin D00280 D002998 DB01068 DEA No. 2737 | DF2374250 DivK1c_000973 EINECS 216-596-2 HMS2093H22 HMS503C07 HSDB 3265 I14-1364 IDI1_000973 Iktorivil Jsp003251 KBio1_000973 Kenoket Klonopin Klonopin (TN) Klonopin Rapidly Disintegrating LS-34156 LS-34260 Landsen Lktorivil Lonazep Melzap MolPort-001-729-088 NINDS_000973 NIOSH/DF2374250 NSC 179913 NSC179913 Oprea1_168772 Paxam RO4023 Ravotril Rivatril Rivoril Rivotril Ro 4-8180 Ro 4023 Ro 5-4023 Ro 5-4023/B-7 Ro 54023 Ro-5-4023 Solfidin UNII-5PE9FDE8GB WLN: T67 GMV JN IHJ CNW KR BG ZINC03813003 clonazepam | |
| | 13 | | Fentanyl | approved, illicit, investigational, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 821 | 437-38-7 | 3345 | 1-Phenethyl-4-(N-phenylpropionamido)piperidine 1-Phenethyl-4-N-propionylanilinopiperidine 1-phenethyl-4-N-propionylanilinopiperidine 437-38-7 5-22-08-00049 (Beilstein Handbook Reference) 80832-90-2 990-73-8 (citrate) AC1L1FQ2 Actiq BIDD:GT0555 BRN 0494484 CHEBI:119915 CHEMBL596 CID3345 D00320 DB00813 Duragesic Duragesic (TN) Duragesic-100 Duragesic-12 Duragesic-25 Duragesic-50 Duragesic-75 Durogesic EINECS 207-113-6 Fentanest Fentanil Fentanil [DCIT] Fentanila Fentanila [INN-Spanish] Fentanilo Fentanyl Fentanyl (JAN/USAN/INN) Fentanyl CII Fentanyl [INN:BAN] Fentanyl citrate Fentanyl-100 Fentanyl-12 Fentanyl-25 | Fentanyl-50 Fentanyl-75 Fentanylum Fentanylum [INN-Latin] HSDB 3329 IONSYS JNS020QD L001275 LS-124439 Matrifen MolPort-003-847-369 N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-Phenethyl-4-piperidyl)propionanilide N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-phenethyl-4-piperidyl)propionanilide N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide N-Phenethyl-4-(N-propionylanilino)piperidine N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenethyl-4-(N-propionylanilino)piperidine N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide NCGC00168252-01 Nasalfent Oprea1_152073 Oprea1_207148 PDSP1_000860 PDSP2_000846 Pentanyl Phentanyl Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI) R 4263 Rapinyl Sentonil Sublimase Sublimaze UNII-UF599785JZ fentanyl | |
| | 14 | | Sufentanil | approved, investigational | Phase 4 | 185 | 56030-54-7 | 41693 | 56030-54-7 60561-17-3 (citrate) AC1L26AJ AC1Q5I7B C08022 C22H30N2O2S CHEBI:127638 CHEBI:9316 CHEMBL658 CID41693 Chronogesic D05938 DB00708 HSDB 6760 L000580 LS-175693 MolPort-004-286-008 N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide | N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide Oprea1_120838 Oprea1_246787 PDSP1_001741 PDSP2_001724 R 30730 R-30730 SUFENTANIL Sufentanil Sufentanil (USAN/INN) Sufentanil Citrate Sufentanil [USAN:BAN:INN] Sufentanilo Sufentanilum Sufentanilum [INN-Latin] Sufentanyl Sulfentanil Sulfentanyl UNII-AFE2YW0IIZ |
| | 15 | | Magnesium Sulfate | approved, vet_approved | Phase 4, Phase 3, Phase 2 | 179 | 7487-88-9 | 24083 | (C10-C16) Alkylalcohol sulfuric acid, magnesium salt 00627_FLUKA 10028-26-9 10034-99-8 (heptahydrate) 13143_RIEDEL 13143_SIAL 139939-75-6 18939-43-0 203726_ALDRICH 208094_SIAL 34276_FLUKA 34276_RIEDEL 38146_FLUKA 38146_RIEDEL 63126_FLUKA 63136_FLUKA 63136_SIAL 63139_FLUKA 63139_SIAL 68081-97-0 7487-88-9 AC1L2N76 AC1LAX36 AC1Q1U66 AI3-02029 Bitter salt C10-C16 Alkyl alcohol sulfuric acid magnesium salt CCRIS 8411 CHEBI:32599 CID24083 CPD0-2390 Caswell No. 534 D008278 DB00653 EINECS 231-298-2 EINECS 233-073-4 EINECS 242-691-3 EINECS 268-365-0 EPA Pesticide Chemical Code 050503 Epsom salt HSDB 664 Hair salt Heptahydrate Magnesium Sulfate Kieserite [as monohydrate] LS-88605 M2643_SIGMA M3409_SIGMA | M7506_SIAL M8150_SIGMA MAGNESIUM SULFATE Magnesium Sulfate In Plastic Container Magnesium Sulfate, Heptahydrate Magnesium Sulphate Hydrate Magnesium bisulfate Magnesium hydrogensulphate Magnesium sulfate Magnesium sulfate (1:1) Magnesium sulfate anhydrous Magnesium sulfate dried Magnesium sulfate heptahydrate Magnesium sulfate hexahydrate Magnesium sulfate in dextrose 5% in plastic container Magnesium sulfate solution Magnesium sulphate Magnesium sulphate anhydrous Magnesium sulphate dried Magnesium sulphate heptahydrate Magnesium(II) sulfate Magnesium(ii) sulfate Magnesiumsulfat MgSO4 MolPort-003-925-000 NSC 146179 OT-S OT-S (drying agent) SDA 15-062-07 Sal Angalis Sal De sedlitz Sal amarum Sal anglicum Sal catharticum Sal seidlitense Salts of england Sel d'angleterre Sulfate, Magnesium Sulfuric acid magnesium salt Sulfuric acid magnesium salt (1:1) Sulfuric acid magnesium salt (VAN) Sulfuric acid, C10-16 alkyl ester, magnesium salt Sulfuric acid, magnesium salt Sulfuric acid, magnesium salt (1:1) Sulfuric acid, mono-C10-16-alkyl esters, magnesium salts Tomix OT UNII-DE08037SAB UNII-ML30MJ2U7I magnesium(2+) ion sulfate |
| | 16 | | Nitric Oxide | approved | Phase 4, Phase 3, Phase 1, Phase 2 | 617 | 10102-43-9 | 145068 | (.)NO (NO)(.) 10102-43-9 14332-28-6 295566_ALDRICH 51005-20-0 51005-21-1 53851-19-7 90452-29-2 AC1L1ADQ AC1L3QHF AC1Q6QZ0 AR-1K7463 Bioxyde d'azote Bioxyde d'azote [French] C00533 CCRIS 4319 CHEMBL1200689 CHEMBL1234765 CID145068 CID945 D00074 D009569 DB00435 EDRF EINECS 233-271-0 Endogenous Nitrate Vasodilator Endothelium-Derived Nitric Oxide HNO HSDB 1246 INOmax INOmax (TN) LS-192158 LS-7547 MolPort-003-929-452 Mononitrogen monoxide Monoxide, Mononitrogen Monoxide, Nitrogen Monoxido de nitrogeno Monoxyde d'azote NITRIC-OXIDE NO NO(.) Nitrate Vasodilator, Endogenous Nitric Oxide, Endothelium Derived | Nitric Oxide, Endothelium-Derived Nitric oxide Nitric oxide (JAN) Nitric oxide 10% by volume or more Nitric oxide trimer Nitric oxide, compressed [UN1660] [Poison gas] Nitric oxide, compressed [UN1660] [Poison gas] Nitrogen monoxide Nitrogen oxide Nitrogen oxide (NO) Nitrogen protoxide Nitrosyl Nitrosyl hydride Nitrosyl hydride ((NO)H) Nitrosyl radical Nitroxide radical Nitroxyl OHM 11771 Oxide, Nitric Oxido de nitrogeno(ii) Oxido nitrico Oxyde azotique Oxyde nitrique Oxyde nitrique [French] RCRA waste no. P076 Stickmonoxyd Stickmonoxyd [German] Stickstoff(II)-oxid Stickstoff(ii)-oxid Stickstoffmonoxid UN 1660 UN1660 UNII-31C4KY9ESH Vasodilator, Endogenous Nitrate [NO] endothelium-derived relaxing factor monoxido de nitrogeno monoxyde d'azote nitric oxide nitrogen monooxide nitrogen monoxide nitrosyl oxido de nitrogeno(II) oxido nitrico oxidonitrogen(.) oxoazanyl oxyde azotique |
| | 17 | | Benzocaine | approved | Phase 4, Phase 3, Phase 1 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 18 | | Bosentan | approved, investigational | Phase 4, Phase 1 | 104 | 147536-97-8 | 104865 | -5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide 147536-97-8 174227-18-0 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide AC-148 AC1L2XN2 Actelion Bosentan Bosentan (INN) Bosentan [USAN:INN:BAN] Bosentan hydrate C27H29N5O6S CHEBI:51450 CHEMBL957 CID104865 D07538 DB00559 | EN002863 HMS2090N14 I06-1873 KS-5062 L001086 LS-31532 MolPort-003-845-300 NCGC00167440-01 PDSP1_001731 PDSP2_001714 Ro 47-0203 Ro 47-0203/039 Ro-47-0203 Ro-47-0203/029 Ro-47-0203/039 TL8001039 Tracleer UNII-XUL93R30K2 bosentan bosentanum bosentán p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide p-tert-Butyl-N-[6-(2-hydroxyethoxy) |
| | 19 | | Zinc | approved | Phase 4, Phase 2, Phase 3 | 2296 | 7440-66-6 | 32051, 23994 | | | 20 | | Menthol | approved | Phase 4, Phase 3, Phase 2 | 2606 | 2216-51-5 | 16666 | (− ()-Menthol (+)-Neo-menthol (+)-p-Menthan-3-ol (+-)-(1R*,3R*,4S*)-Menthol (+-)-Menthol (+/-)-Menthol (+/-)-p-Menthan-3-ol (-)-(1R,3R,4S)-Menthol (-)-Menthyl alcohol (-)-menthol (-)-p-Menthan-3-ol (-)-trans-p-Menthan-cis-ol (1R)-(-)-Menthol (1R,2S,5R)-(-)-menthol (1R,2S,5R)-Menthol (1R,3R,4S)-(-)-MENTHOL (1R,3R,4S)-(-)-Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol (1S, 2S, 5R)-(+)-Neomenthol (1S,2R,5R)-(+)-Isomenthol (1S,2R,5S)-(+)-Menthol (1S,2R,5S)-Menthol (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol (1r,2s,5r)-(-)-menthol (L)-MENTHOL (R)-(-)-Menthol (r)-(-)-menthol )-Menthol --MENTHOL 1-Menthol 1490-04-6 15356-60-2 15356-70-4 15785_RIEDEL 15785_SIAL 19863P 2-Isopropyl-5-methylcyclohexanol 20747-49-3 2216-51-5 3-p-Menthol 4-Isopropyl-1-methylcyclohexan-3-ol 491-02-1 5-Methyl-2-(1-methylethyl)-cyclohexanol 5-Methyl-2-(1-methylethyl)cyclohexanol 5-methyl-2-(propan-2-yl)cyclohexanol 5-methyl-2-propan-2-ylcyclohexan-1-ol 551376_ALDRICH 551376_FLUKA 588733_ALDRICH 613290_ALDRICH 613290_FLUKA 63660_FLUKA 63670_ALDRICH 63670_FLUKA 63975-60-0 6C6A4A8C-A054-468C-A1F0-F29E39838CF2 89-78-1 98167-53-4 AC1L1B2E AC1L28FR AC1Q1NQ2 AC1Q2QQM AI3-08161 AI3-52408 AKOS000119740 AR-1J3337 BB_NC-0057 BRN 1902288 BRN 3194263 BSPBio_003062 C00400 C10H20O CCRIS 3728 CCRIS 375 CCRIS 4666 CCRIS 9231 CHEBI:15409 CHEBI:545611 CHEMBL256087 CHEMBL470670 CID1254 CID16666 Caswell No. 540 D-(-)-Menthol D-p-Menthan-3-ol D00064 D008610 D04849 D04918 DB00825 DivK1c_000820 EINECS 201-939-0 EINECS 207-724-8 EINECS 216-074-4 EINECS 218-690-9 EINECS 239-387-8 EINECS 239-388-3 EPA Pesticide Chemical Code 051601 FEMA No. 2665 Fisherman's friend lozenges Fisherman's friend lozenges (TN) HMS1922G13 HMS2092L14 HMS502I22 | HSDB 5662 HSDB 593 Headache crystals Hexahydrothymol I06-1216 I14-7371 IDI1_000820 KBio1_000820 KBio2_000785 KBio2_003353 KBio2_005921 KBio3_002562 KBioSS_000785 L-(-)-Menthol L-(-)-menthol L-Menthol L-menthol LMPR0102090001 LS-2353 LS-57201 LS-886 LS-89531 LS-89533 Levomenthol Levomenthol [INN:BAN] Levomentholum Levomentholum [INN-Latin] Levomentol M0321 M0545 M2772_SIAL MENTHOL MLS002207256 Menthacamphor Menthol Menthol (USP) Menthol (VAN) Menthol natural Menthol natural, brazilian Menthol racemic Menthol racemique Menthol racemique [French] Menthol solution Menthol, (1alpha,2beta,5alpha)-Isomer Menthomenthol Menthyl alcohol MolPort-000-849-729 MolPort-001-793-392 NCGC00159382-02 NCGC00159382-03 NCGC00164247-01 NCGC00164247-02 NCI-C50000 NINDS_000820 NOOLISFMXDJSKH-KXUCPTDWBX NSC 2603 NSC 62788 NSC2603 NSC62788 Neoisomenthol Peppermint camphor RACEMIC MENTHOL U.S.P. Racementhol Racementhol [INN:BAN] Racementholum Racementholum [INN-Latin] Racementol Racementol [INN-Spanish] Racemic menthol Robitussin Cough Drops SDCCGMLS-0066659.P001 SMR001306785 SPBio_000869 SPECTRUM1503134 STK802468 Spectrum2_000855 Spectrum3_001561 Spectrum5_001060 Spectrum_000305 Tra-kill tracheal mite killer U.S.P. Menthol U.S.p. Menthol UNII-BZ1R15MTK7 UNII-L7T10EIP3A UNII-YS08XHA860 W266507_ALDRICH W266523_ALDRICH W266590_ALDRICH WLN: L6TJ AY1&1 BQ D1 WLN: L6TJ AY1&1 DQ D1 -L ZINC01482164 cis-1 ,3-trans-1,4-(+-)-menthol cis-1,3-trans-1,4-(+-)-menthol d,l-Menthol d-Menthol d-Neomenthol dl-3-p-Menthanol dl-Menthol dl-Menthol (JP15) l-(-)-Menthol l-Menthol l-Menthol (JP15) l-Menthol (TN) l-Menthol (natural) nchembio862-comp1 p-Menthan-3-ol rac-Menthol |
| | 21 | | Indomethacin | approved, investigational | Phase 4, Phase 1, Phase 2 | 116 | 53-86-1 | 3715 | 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid 1z9h 37242-43-6 503560-73-4 53-86-1 74252-25-8 (hydrochloride salt, tri-hydrate) 7681-54-1 (hydrochloride salt) 91853-74-6 AB00052022 AC-532 AC1L1GJQ AKOS000592893 Aconip Aconip (TN) Amuno Apo-Indomethacin Arthrexin Artracin Artrinovo Artrivia BIDD:GT0132 BIM-0050670.0001 BPBio1_000160 BRD-K57222227-001-06-1 BRN 0497341 BSPBio_000144 BSPBio_001149 BSPBio_002176 Bio-0704 Bio2_000405 Bio2_000885 Bonidin Bonidon Bonidon Gel C01926 CAS-53-86-1 CCRIS 3502 CHEBI:49662 CHEMBL6 CID3715 CPD-10545 Catlep Chibro-amuno Chrono-indicid Chrono-indocid Confortid D00141 DB00328 DESMETHYL INDOMETHACIN DivK1c_000271 Dolcidium Dolcidium PL Dolovin Durametacin EINECS 200-186-5 EU-0100692 Elmetacin Flexin continus HMS1362I11 HMS1568H06 HMS1792I11 HMS1920F21 HMS1990I11 HMS2089N19 HMS2091N09 HMS500N13 HSDB 3101 Hicin I 7378 I0655 I7378_SIGMA I8280_SIGMA IDI1_000271 IDI1_002160 IMN IN1454 Idomethine Imbrilon Inacid Indacin Indameth Indmethacine Indo-Lemmon Indo-Spray Indo-phlogont Indo-rectolmin Indo-tablinen Indocid Indocid (pharmaceutical) Indocid Pda Indocid Sr Indocin Indocin (TN) Indocin I.V Indocin I.V. Indocin Sr Indolar SR Indomecol Indomed Indomee Indomet 140 Indometacin Indometacin (JP15/INN) Indometacina Indometacina [INN-Spanish] Indometacine Indometacine [INN-French] Indometacinum | Indometacinum [INN-Latin] Indometacyna Indometacyna [Polish] Indomethacin Indomethacin & MAP-30 Indomethacin (USP) Indomethacin [USAN:BAN] Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin Indomethacine Indomethacinum Indomethancin Indomethazine Indomethegan Indomethine Indometicina Indometicina [Spanish] Indomo Indomod Indoptic Indoptol Indorektal Indoxen Inflazon Infrocin Inteban sp KBio1_000271 KBio2_000489 KBio2_001399 KBio2_003057 KBio2_003967 KBio2_005625 KBio2_006535 KBio3_000897 KBio3_000898 KBio3_001396 KBioGR_000395 KBioGR_000489 KBioSS_000489 KBioSS_001399 L000959 LS-187 LS-82147 Lausit Liometacen Lopac-I-7378 Lopac0_000692 MLS000069402 MLS000758212 MLS001074194 Metacen Metartril Methazine Metindol Mezolin Miametan Mikametan Mobilan MolMap_000032 MolPort-000-917-894 NCGC00015562-01 NCGC00015562-02 NCGC00015562-03 NCGC00015562-08 NCGC00015562-19 NCGC00024135-02 NCGC00024135-04 NCGC00024135-05 NCGC00024135-06 NCGC00024135-07 NCGC00024135-08 NCGC00024135-09 NCGC00024135-11 NCI-C56144 NCI60_041708 NINDS_000271 Novo-Methacin Novomethacin Oprea1_686105 Prestwick0_000272 Prestwick1_000272 Prestwick2_000272 Prestwick3_000272 Prestwick_597 Reumacide Rhemacin LA Rheumacin LA S00108 S1723_Selleck SMR000058195 SMR000449290 SPBio_000979 SPBio_002363 SPECTRUM1500350 Sadoreum Spectrum2_000970 Spectrum3_000468 Spectrum4_000018 Spectrum5_000868 Spectrum_000919 Tannex Tocris-1708 UNII-XXE1CET956 UPCMLD-DP023 UPCMLD-DP023:001 USAN Vonum indometacin indomethacin nchembio.147-comp11 {1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid |
| | 22 | | Nebivolol | approved, investigational | Phase 4 | 82 | 152520-56-4, 99200-09-6, 118457-14-0 | 71301 | 1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol 1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol 104365-59-5 118457-14-0 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] 99200-09-6 AC-1611 AC1L2FX8 AC1Q4OMF Bystolic C22H25F2NO4 CHEMBL434394 CID71301 D05127 DB04861 I06-0378 L001284 LS-178404 Lobivon MolPort-003-849-343 Narbivolol Nebicard-5 | Nebilet Nebilong Nebipill Nebivolol Nebivolol (USAN/INN) Nebivolol [USAN:INN:BAN] Nebivololum Nebivololum [Latin] Nebivololum [latin] Nodon Nubeta PDSP1_000244 PDSP2_000243 PI-21858 R 67555 R-67555 R65,824 UNII-030Y90569U alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) alpha,alpha'-(Iminodimethylene)bis(6-fluoro-2-chromanmethanol) alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol) nebivololum [latin] | |
| | 23 | | Dutasteride | approved, investigational | Phase 4 | 114 | 164656-23-9 | 152945, 6918296 | (1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide (5.alpha.,17.beta.)-N-{2,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide 164656-23-9 AC1L49EM AC1OCF98 Avodart Avodart (TN) Avodart, Dutasteride Avolve Bio-0167 C27H30F6N2O2 CHEBI:132773 CHEMBL1200969 CHEMBL283245 CID152945 CID6918296 CID9914880 D03820 | DB01126 Duagen Dutasteride Dutasteride (JAN/USAN/INN) Dutasteride [USAN] FT-0080365 GG 745 GG-745 GI 198745 GI-198745 GI-198745X LS-173584 MolPort-003-666-660 MolPort-003-847-041 N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide NSC740477 S1202_Selleck UNII-O0J6XJN02I ZINC03932831 alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide | |
| | 24 | | Rocuronium | approved | Phase 4, Phase 3 | 283 | 119302-91-9, 143558-00-3 | 441290 | (2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane 143558-00-3 AC1L9AWM BIDD:GT0360 C07556 CHEBI:8884 CID441290 | DB00728 Esmeron HMS2090E03 NCGC00167433-01 Rocuronium Rocuronium bromide Zemuron [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate | |
| | 25 | | Carvedilol | approved, investigational | Phase 4 | 168 | 72956-09-3 | 2585 | (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol (+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol (+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol 107741-96-8 72956-09-3 AB1004830 AC-1641 AC1L1E0B Artist Artist (TN) Atlana Pharma brand of carvedilol BM 14190 BM-14-190 BM-14.190 BM-14190 BRD-A10977446-001-04-8 BRD-A10977446-045-01-1 Bio-0014 C043211 C06875 C2260 C24H26N2O4 CHEBI:3441 CHEMBL723 CID2585 CPD000449280 Carvedilol Carvedilol (JAN/USAN/INN) Carvedilol [USAN:INN:BAN:JAN] Carvedilolum Carvedilolum [Latin] Coreg Coreg (TN) Coreg CR Coropres Coropress D00255 DB01136 DQ 2466 DQ-2466 Dibloc | Dilatrend EG-P042 Eucardic GlaxoSmithKline brand of carvedilol HMS2051N03 HMS2089B09 HMS2093E12 HSDB 7044 I06-0064 I06-1477 KBio2_002145 KBio2_004713 KBio2_007281 KBio3_002323 KBioGR_001252 KBioSS_002145 Kredex L001243 LS-121875 Lakeside brand of carvedilol MLS000758299 MLS000759508 MLS001424092 MolPort-003-666-814 NCGC00167832-01 NCGC00167832-02 NCGC00167832-03 Querto Roche brand of carvedilol SAM001246736 SAM001247021 SK&F-105517 SKF 105517 SMR000449280 SPBio_001885 STK621453 Spectrum2_001673 Spectrum3_001182 Spectrum4_000636 Spectrum5_001436 Spectrum_001665 TL8005080 UNII-0K47UL67F2 carvedilol carvedilol, (+-)-isomer carvedilol, (R)-isomer carvedilol, (S)-isomer carvedilol, 14C-labeled |
| | 26 | | Memantine | approved, investigational | Phase 4 | 181 | 19982-08-2 | 4054 | 1,3-Dimethyl-5-adamantanamine 1-Amino-3,5-dimethyladamantane 19982-08-2 3,5-Dimethyl-1-adamantanamine 3,5-Dimethyl-1-adamantylamine 3,5-Dimethyl-1-aminoadamantane 3,5-Dimethyladamantan-1-ylamine 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine 3,5-dimethyladamantan-1-amine 3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine 41100-52-1 (Hydrochloride) 51052-62-1 AB00053600 AC1L1HB7 AKOS000113995 BBL000737 BPBio1_001117 BPBio1_001270 BSPBio_001015 Biomol-NT_000209 C13736 CBMicro_020348 CHEBI:152523 CHEMBL807 CID4054 D08174 DB01043 DMAA DivK1c_000068 EU-0053634 Ebixa Exiba Exiba (TN) HMS500D10 HSDB 7327 IDI1_000068 KBio1_000068 KBio2_001087 KBio2_003655 | KBio2_006223 KBio3_001926 KBioGR_001543 KBioSS_001087 LS-157051 Lopac0_000861 Memantin Memantina Memantina [INN-Spanish] Memantine Memantine (INN) Memantine HCL Memantine Hydrochloride Memantine [INN:BAN] Memantine [INN] Memantinum Memantinum [INN-Latin] MolPort-002-041-858 NCGC00015705-05 NCGC00024782-02 NCGC00024782-03 NINDS_000068 Namenda Oprea1_480562 Prestwick0_000978 Prestwick1_000978 Prestwick2_000978 Prestwick3_000978 SPBio_001456 SPBio_002926 ST057652 STK520682 Spectrum2_001408 Spectrum3_000923 Spectrum4_001022 Spectrum5_001355 Spectrum_000607 UNII-W8O17SJF3T ZERO/006024 memantine | |
| | 27 | | Acetazolamide | approved, vet_approved | Phase 4, Phase 2, Phase 3 | 80 | 59-66-5 | 1986 | 1424-27-7 (mono-hydrochloride salt) 1yda 1ydb 1ydd 1zsb 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide 2h4n 3czv 4-Diamox 5-acetamido-1,3,4-thiadiazole-2-sulfonamide 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide 5661-25-6 59-66-5 8017-69-4 A 6011 A6011_SIAL A6011_SIGMA AB00051906 AC-12779 AC1L1CO5 AI3-52458 AKOS000715163 Acetadiazol Acetamidothiadiazolesulfonamide Acetamox Acetazolam Acetazolamid Acetazolamida Acetazolamida [INN-Spanish] Acetazolamide (AAZ) Acetazolamide (JP15/USP/INN) Acetazolamide Apotex Brand Acetazolamide Chiesi Brand Acetazolamide Dioptic Brand Acetazolamide Grin Brand Acetazolamide ICN Brand Acetazolamide Jumer Brand Acetazolamide Llorens Brand Acetazolamide Medphano Brand Acetazolamide Novopharm Brand Acetazolamide Orion Brand Acetazolamide Sodium Acetazolamide Sodium, (Sterile) Acetazolamide Wassermann Brand Acetazolamide [INN:BAN:JAN] Acetazolamide, Monosodium Salt Acetazolamidum Acetazolamidum [INN-Latin] Acetazolamine Acetazoleamide Acetozalamide Acétazolamide Ak Zol Ak-Zol AkZol Apo Acetazolamide Apo-Acetazolamide ApoAcetazolamide Apotex Brand of Acetazolamide Atenezol BAS 01585728 BIDD:GT0643 BPBio1_000007 BSPBio_000005 BSPBio_001788 C06805 C4H6N4O3S2 CAS-59-66-5 CCRIS 5811 CHEBI:27690 CHEMBL20 CID1986 CPD0-1626 CPD000058394 Carbonic Anhydrase Inhibitor 6063 Carbonic Anhydrase Inhibitor No. 6063 Carbonic anhydrase inhibitor 6063 Chiesi Brand of Acetazolamide Ciba Vision Brand of Acetazolamide Cidamex D000086 D00218 DB00819 Dazamide Defiltran Dehydratin Diacarb Diakarb Diamox Diamox (TN) Diamox Sequels Didoc Diluran | Dioptic Brand of Acetazolamide Diuramid Diuramide Diureticum-Holzinger Diureticum-holzinger Diuriwas Diutazol DivK1c_000017 Donmox Duiramid EINECS 200-440-5 EU-0100039 Edemox Eumicton Fonurit Glauconox Glaumox Glaupax Glupax Grin Brand of Acetazolamide HMS1568A07 HMS1920A05 HMS2091G05 HMS500A19 HSDB 3002 Huma Zolamide Huma-Zolamide HumaZolamide I09-0425 ICN Brand of Acetazolamide IDI1_000017 Jumer Brand of Acetazolamide KBio1_000017 KBio2_000358 KBio2_002926 KBio2_005494 KBio3_001288 KBioGR_000558 KBioSS_000358 LS-10227 Llorens Brand of Acetazolamide Lopac-A-6011 Lopac0_000039 MLS000028435 MLS001148438 Medphano Brand of Acetazolamide MolPort-001-783-578 Monosodium Salt Acetazolamide N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide NCGC00015074-01 NCGC00015074-02 NCGC00015074-03 NCGC00015074-06 NCGC00015074-11 NCGC00023455-03 NCGC00023455-04 NCGC00023455-05 NCGC00023455-06 NCGC00023455-07 NINDS_000017 NSC 145177 NSC145177 Natrionex Nephramid Nephramide Novopharm Brand of Acetazolamide Orion Brand of Acetazolamide Phonurit Prestwick0_000003 Prestwick1_000003 Prestwick2_000003 Prestwick3_000003 Prestwick_4 SAM002554883 SBB056640 SK-acetazolamide SMR000058394 SPBio_000004 SPBio_001926 SPECTRUM1500102 Sk-Acetazolamide Spectrum2_000082 Spectrum3_000284 Spectrum4_000139 Spectrum5_000738 Spectrum_000018 Storz Brand of Acetazolamide Preparation Storzolamide UNII-O3FX965V0I Vetamox WLN: T5NN DSJ CSZW EMV1 Wassermann Brand of Acetazolamide Wyeth Brand of Acetazolamide Preparation acetazolamide |
| | 28 | | Nifedipine | approved | Phase 4 | 118 | 21829-25-4 | 4485 | 101539-70-2 101554-38-5 21829-25-4 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester 5-22-04-00268 (Beilstein Handbook Reference) 60299-11-8 (mono-hydrochloride) AC-11618 AC1L1I9V AC1Q4254 AKOS002942507 ARONIS24171 AWD Pharma Brand of Nifedipine Adalat Adalat (TN) Adalat 10 Adalat 20 Adalat 5 Adalat CC Adalat CR Adalat Crono Adalat FT Adalat Ft Adalat GITS Adalat GITS 30 Adalat Gits Adalat Gits 30 Adalat LA Adalat LP Adalat Oros Adalat PA Adalat Retard Adalat XL Adalate Adalate LP Adapine Adapress Adcock Ingram Brand of Nifedipine Adipine XL Afeditab Afeditab CR Afeditab CR (TN) Alat Aldipin Alfadal Alonix Alonix S Alpha-Nifedipine Retard Angipec Anifed Anpine Apo-Nifed Aprical Aprical long BAY 1040 BAY A 1040 BAY-a 1040 BAYa1040 BCBcMAP01_000046 BIDD:GT0442 BIDD:PXR0034 BIM-0050796.0001 BPBio1_000271 BRN 0497773 BSPBio_000245 BSPBio_001391 BSPBio_002071 Bay-1040 Bay-a-1040 Bay1040 Bayer Brand of Nifedipine Bio-0733 Bio1_000112 Bio1_000601 Bio1_001090 Bio2_000111 Bio2_000591 Bonacid C07266 C17H18N2O6 CAS-21829-25-4 CBiol_001826 CCRIS 6074 CHEBI:7565 CHEMBL193 CID4485 CPD000058291 Calcibloc Calcigard Calcilat Camont Cardifen Cardilat Cardionorm Chronadalate Chronadalate LP Chronadalate Lp Citilat Coracten Coracten XL Coral Cordafen Cordaflex Cordalat Cordicant Cordilan Cordipin Cordipine Corinfar Corotrend Corynphar D00437 D009543 DB01115 Depin Dignokonstant Dilafed Dilcor Dipinkor DivK1c_000313 Duranifin EINECS 244-598-3 EU-0100819 Ecodipi Ecodipin Ecodipin E Emaberin Fedcor Fedcor Retard Fenamon Fenamon SR Fenamon Sr Fenigidin Fenihidin Fenihidine Fortipine LA Glopir HMS1361F13 HMS1568M07 HMS1791F13 HMS1920P19 HMS1989F13 HMS2051O03 HMS2089H11 HMS2091H20 | HMS500P15 Hadipin Hexadilat I06-0051 I06-1286 IDI1_000313 IDI1_033861 Infedipin Introcar KB-1712P KBio1_000313 KBio2_000111 KBio2_001459 KBio2_002400 KBio2_002679 KBio2_004027 KBio2_004968 KBio2_005247 KBio2_006595 KBio2_007536 KBio3_000221 KBio3_000222 KBio3_001571 KBio3_002879 KBioGR_000111 KBioGR_000627 KBioGR_002400 KBioSS_000111 KBioSS_001459 KBioSS_002405 KRKA Brand of Nifedipine Kordafen Korinfar L001054 LS-1012 Lopac-N-7634 Lopac0_000819 MLS000028521 MLS000758222 MLS001148146 MLS001401371 Macorel Megalat MolPort-000-787-707 MolPort-006-822-492 Monohydrochloride, Nifedipine Myogard N 7634 N0528 N1fedilat N7634_SIGMA NCGC00015748-01 NCGC00015748-02 NCGC00015748-03 NCGC00015748-06 NCGC00015748-13 NCGC00024983-01 NCGC00024983-02 NCGC00024983-03 NCGC00024983-04 NCGC00024983-05 NCGC00024983-06 NCGC00024983-07 NCGC00024983-08 NCGC00091707-01 NINDS_000313 Nedipin Nicardia Nifangin Nifar Nifdemin Nifebene Nifecard Nifecor Nifedepat Nifediac Nifedical Nifedical XL Nifedicor Nifedin Nifedine Nifedipine Nifedipine (JP15/USP/INN) Nifedipine Bayer Brand Nifedipine GTIS Nifedipine KRKA Brand Nifedipine Monohydrochloride Nifedipine Orion Brand Nifedipine Pfizer Brand Nifedipine Retard Nifedipine [USAN:BAN:INN:JAN] Nifedipine-GTIS Nifedipino Nifedipino [INN-Spanish] Nifedipinum Nifedipinum [INN-Latin] Nifedipres Nifedirex LP Nifelan Nifelat Nifelat Q Nifelate Nifensar XL Nificard Nifidine Nifipen Niphedipine Oprea1_788617 Orion Brand of Nifedipine Orix Oxcord Pfizer Brand of Nifedipine Pidilat Prestwick0_000063 Prestwick1_000063 Prestwick2_000063 Prestwick3_000063 Prestwick_357 Procardia Procardia (TN) Procardia XL S1808_Selleck SAM001246963 SMR000058291 SPBio_001016 SPBio_002166 SPECTRUM1500431 STK735567 Sepamit Slofedipine XL Spectrum2_001058 Spectrum3_000516 Spectrum4_000074 Spectrum5_001278 Spectrum_000979 Tensipine MR Tibricol Tocris-1075 UNII-I9ZF7L6G2L Vascard ZINC19594578 Zenusin cMAP_000042 nchembio.95-comp13 nifedipine | |
| | 29 | | Methazolamide | approved | Phase 4, Phase 1, Phase 2 | 7 | 554-57-4 | 4100 | 2-Acetylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide 4-27-00-08221 (Beilstein Handbook Reference) 5-Acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide 554-57-4 AB00490015 AC1L1HEV AC1Q40D8 AC1Q40D9 BPBio1_000731 BRD-K71053238-001-03-6 BRD-K71053238-001-04-4 BRN 0232387 BSPBio_000663 BSPBio_003508 C07764 C5H8N4O3S2 CAS-554-57-4 CHEBI:101124 CHEMBL19 CID4100 CPD001496938 D00655 D008704 DB00703 DivK1c_000582 EINECS 209-066-7 HMS1570B05 HMS1922M19 HMS2093A05 HMS501N04 HSDB 3269 I09-1225 IDI1_000582 KBio1_000582 KBio2_002095 KBio2_004663 KBio2_007231 KBio3_003013 KBioGR_000739 KBioSS_002095 LS-10006 M4156_FLUKA M4156_SIGMA MLS000028532 MLS001146905 MZM Metazolamida Metazolamida [INN-Spanish] | Metazolamide Metazolamide [DCIT] Methazolamid Methazolamide (JAN/USP/INN) Methazolamide (MZA) Methazolamide [INN:BAN:JAN] Methazolamidum Methazolamidum [INN-Latin] Methenamide MolPort-001-791-152 Méthazolamide N Methylacetazolamide N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide N-(3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene)acetamide N-(4-Methyl-2-sulfamoyl-Delta2-1,3,4-thiadiazolin-5-ylidene) acetamide N-(4-Methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)acetamide N-Methylacetazolamide N-[(2E)-5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide NCGC00016508-01 NCGC00018188-01 NCGC00022950-03 NCGC00022950-04 NCGC00178022-01 NCGC00178022-02 NINDS_000582 Naptazane Neptazane Neptazane (TN) Neptazaneat Oprea1_161738 Prestwick0_000802 Prestwick1_000802 Prestwick2_000802 Prestwick3_000802 Prestwick_1007 SAM002589943 SMR000058287 SPBio_001386 SPBio_002584 SPECTRUM1503252 ST081366 Spectrum2_001543 Spectrum3_001914 Spectrum4_000190 Spectrum5_001006 Spectrum_001615 UNII-W733B0S9SD ZINC12503151 methazolamide | |
| | 30 | | Dexmedetomidine | approved, vet_approved | Phase 4, Phase 2, Phase 3, Early Phase 1 | 592 | 76631-46-4, 113775-47-6 | 68602, 5311068, 56032 | (+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole (+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole (+)-medetomidine (S)-medetomidine 113775-47-6 4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole 4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole AC1NSJXT C07450 CHEBI:4466 CHEMBL778 CID5311068 D00514 DEXMEDETOMIDINE | Dexdor (T) Dexmedetomidin Dexmedetomidina Dexmedetomidine Dexmedetomidine (USAN/INN) Dexmedetomidinum Dexmédétomidine MPV 1440 MPV-1440 Medetomidina [Spanish] Medetomidine Medetomidinum [Latin] NCGC00025347-01 PRECEDEX Precedex (TN) Tocris-2023 ZINC04632106 |
| | 31 | | Telmisartan | approved, investigational | Phase 4 | 268 | 144701-48-4 | 65999 | 144701-48-4 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid 4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid 4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid 4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid 4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid 4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid AC-2013 AC1L24EB AC1Q5U7O Abbott brand of telmisartan BAY-68-9291 BAY68-9291 BIBR 277 BIBR 277SE BIBR-277 BIBR-277-SE BIBR-277SE BIDD:GT0365 BRD-K73999723-001-02-2 BSPBio_002738 Bay 68-9291 Bio-0103 Boehringer Ingelheim brand of telmisartan C07710 C084178 C33H30N4O2 CHEBI:9434 CHEMBL1017 CID65999 CPD000466326 D00627 DB00966 Glaxo Wellcome brand of telmisartan GlaxoSmithKline brand of telmisartan | HMS1922P07 HMS2051P16 HMS2090P17 HMS2093M22 HSDB 7590 I06-0281 KBio3_001958 KBioGR_001842 Kinzal Kinzalmono L001035 LS-44263 MLS000759432 MLS001076687 Micardis Micardis (TN) Micardis HCT Micardis, Targit, Temax, BIBR277, Telmisartan MolPort-003-666-621 NCGC00095150-01 NCGC00095150-02 NCGC00095150-03 Pritor S1738_Selleck SAM001246602 SMR000466326 SPBio_002131 SPECTRUM1505261 STK624049 Spectrum2_001976 Spectrum3_001089 Spectrum4_001261 Spectrum5_001053 TL8000991 Telmisartan Telmisartan (JAN/USAN/INN) Telmisartan [USAN:INN] UNII-U5SYW473RQ YM-086 telmisartan | |
| | 32 | | Doxapram | approved, vet_approved | Phase 4 | 7 | 309-29-5 | 3156 | (+-)-Doxapram (+-)-doxapram 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one 2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl- (9CI) 309-29-5 AC-12510 AC1L1FAQ BRN 0628691 C24H30N2O2 CHEBI:681848 CHEMBL1754 CID3156 D07873 DB00561 Docatone | Docatone (TN) Dopram Doxapram Doxapram (INN) Doxapram HCL Doxapram [USP:JAN] Doxapram hydrochloride Doxapramum Doxapramum [INN-Latin] EINECS 206-216-3 HSDB 3318 LS-138811 MolPort-005-933-844 NCGC00167459-01 Oprea1_016788 STK634791 UNII-94F3830Q73 doxapram | |
| | 33 | | Alprostadil | approved, investigational | Phase 4 | 71 | 745-65-3 | 149351 | (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid (13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate 119314-69-1 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid 745-65-3 82474_FLUKA A0593_SIAL AB00514004 AC-6095 AC1NQXHQ Alista Alprostadil Alprostadil (JP15/USP/INN) Alprostadil Alfadex Alprostadil Prostoglandin E1 Alprostadilum Alprox-TD BIDD:GT0747 BML1-F06 BPBio1_001293 BRD-K52459643-001-06-0 BSPBio_001175 BSPBio_001488 Befar Befar (TN) C04741 CHEBI:15544 CHEMBL495 CID5280723 CPD000112594 Caverject D00180 DB00770 Edex FemLife Femprox HEI-507 HMS1361K10 HMS1571K17 HMS1791K10 HMS1989K10 HMS2052L11 | HMS2090L08 IDI1_033958 LMFA03010134 MLS000758964 MLS001424250 MR 256 MR-256 MolPort-003-939-183 Muse NCGC00025234-02 NCGC00025234-03 NCGC00025234-04 NCGC00025234-05 P5515_SIAL P5515_SIGMA P7527_SIGMA P8908_SIGMA PGE-1 PGE1 PGE1 Oligomer PGE1 α-CD PGE₁ Prestwick2_001018 Prestwick3_001018 Prink Prink (TN) Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer Prostaglandin E1 Prostaglandin e1 Prostavasin Prostin VR Prostin VR Pediatric Prostin VR pediatric (TN) Prostin vr RayVa SAM001246840 SAM001246845 SAM001247093 SMP2_000271 SMR000112594 ST50826271 Sugiran Topiglan U-10136 Viridal Vitaros alprostadil l-Prostaglandin E1 | |
| | 34 | | Etomidate | approved | Phase 4 | 65 | 33125-97-2 | 36339, 667484 | (+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate (+)-Etomidate (+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate (+)-etomidate (R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester (d)-Etomidate 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester 1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester 1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester 15301-65-2 1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester 3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester 3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester 33125-97-2 AC-5898 AC1L1VLF AC1Q34BV AC1Q64LP AKOS000548952 Absele Amidate Amidate (TN) Amidate (pharmaceutical) Amidate, Etomidate BAS 01947657 BRN 0665833 C07522 C14H16N2O2 CHEBI:129025 CHEMBL23731 CID36339 CPD000010931 D-Etomidate D005045 D00548 | DB00292 EINECS 251-385-9 Ethnor Ethomidate Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate Etomidate Etomidate (USAN/INN) Etomidate [USAN:BAN:INN] Etomidato Etomidato [INN-Spanish] Etomidatum Etomidatum [INN-Latin] Etomidic acid HMS1571A04 HMS1612G10 HMS2093P17 Hypnomidate LS-78232 MLS000034952 MLS001240191 MolPort-000-917-569 Prestwick0_001041 Prestwick1_001041 Prestwick2_001041 R 16659 R 26490 R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate R-26490 R26490 Radenarcon Radenarkon S1329_Selleck SAM002548930 SBB066197 SMR000010931 SPBio_002901 UNII-Z22628B598 ethyl 3-(1-phenylethyl)imidazole-4-carboxylate |
| | 35 | | Captopril | approved | Phase 4 | 34 | 62571-86-2 | 44093 | (2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S) 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline 1j37 3-Mercapto-2-methylpropionyl-proline 62571-86-2 AC-12047 AC1L2B4L AC1Q29GZ AC1Q5R48 Acediur Aceplus Acepress Acepril Alopresin Apopril Apopril (TN) Asisten BB_NC-2104 BIM-0050290.0001 BPBio1_000063 BRD-K54529596-001-04-0 BSPBio_000057 BSPBio_002976 C 4042 C4042_SIAL C4042_SIGMA C8856_SIAL C9H15NO3S CHEBI:3380 CHEMBL1560 CHEMBL82 CID44093 CP CPD0-2067 CPD000059061 Capoten Capoten (TN) Captolane Captopril (JP15/USP/INN) Captopril [USAN:INN:BAN:JAN] Captoprilum Captoprilum [INN-Latin] Captopryl Captoril Captril Cesplon D-2-Methyl-3-mercaptopropanoyl-L-proline D-3-Mercapto-2-methylpropanoyl-L-proline D-3-Mercapto-2-methylpropionylproline D00251 DB01197 Dilabar DivK1c_000208 EINECS 263-607-1 EU-0100302 FT-0082749 Garranil Garranil (discontinued) HMS1921C12 HMS2089P19 | HMS2092I12 HMS500K10 HSDB 6527 Hipertil Hypertil IDI1_000208 Isopresol KBio1_000208 KBio2_001168 KBio2_003736 KBio2_006304 KBio3_002196 KBioGR_001321 KBioSS_001168 L-Captopril LS-137465 Lopac-C-4042 Lopac0_000302 Lopirin Lopirin [Switzerland] Lopril MCO MLS000069484 MLS001076488 MolPort-001-794-639 N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline NCGC00015235-01 NCGC00015235-02 NCGC00023654-03 NCGC00023654-04 NCGC00023654-05 NCGC00023654-06 NCGC00023654-07 NCGC00023654-08 NCGC00023654-09 NCGC00023654-10 NINDS_000208 Prestwick3_000019 Prestwick_103 SA 333 SAM002564201 SMP1_000056 SMR000059061 SPBio_001022 SPECTRUM1500682 SQ 14,225 SQ 14225 SQ-14,225 SQ-14,534 SQ-14225 SQ-14534 ST079562 STK802012 Spectrum2_001211 Spectrum3_001388 Spectrum4_000811 Spectrum5_001587 Spectrum_000688 Tenosbon Tensiomin Tensobon Tensoprel UNII-9G64RSX1XD UPCMLD-DP003 UPCMLD-DP003:001 X8Z [2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline captopril | |
| | 36 | | Desflurane | approved | Phase 4 | 150 | 57041-67-5 | 42113 | (+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether 1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane 1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane 2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane 57041-67-5 AC1L274J AC1Q4ICY C07519 C3H2F6O CHEBI:4445 CHEMBL1200733 CID42113 D00546 DB01189 DESFLURANE Desflurane | Desflurane (JAN/USP/INN) Desflurane [USAN:INN] Desflurano Desflurano [INN-Spanish] Desfluranum Desfluranum [INN-Latin] Difluoromethyl 1,2,2,2-tetrafluoroethyl ether I 653 I-653 I653 LS-65505 MolPort-001-776-387 PC6781E Suprane Suprane (TN) UNII-CRS35BZ94Q difluoromethyl 1,2,2,2-tetrafluoroethyl ether r-e 236ea1 |
| | 37 | | Nicorandil | approved | Phase 4 | 17 | 65141-46-0 | 47528 | 2 Nicotinamidethyl Nitrate 2 Nicotinamidoethyl Nitrate 2-(Nicotinamido)ethyl nitrat 2-(Pyridine-3-carboxamido)ethyl Nitrate 2-(pyridine-3-carbonylamino)ethyl nitrate 2-Nicotinamidethyl Nitrate 2-Nicotinamidoethyl nitrate 2-[(pyridin-3-ylcarbonyl)amino]ethylnitrat 65141-46-0 AC-4690 AC1L2I8U AC1Q5PMV AKOS001589705 ARONIS24318 Adancor Aventis Brand of Nicorandil Aventis Pharma Brand of Nicorandil BRD-K97752965-001-01-6 BRN 0481451 Bio-0696 C13280 C8H9N3O4 CHEMBL284906 CID47528 CPD000466365 D01810 D020108 Dancor EINECS 265-514-1 HMS2051N16 HMS2089L12 I06-0032 Ikorel LS-130673 | MLS000759488 MLS001424162 MLS002222323 Merck Brand of Nicorandil Merck Lipha Sante Brand of Nicorandil MolPort-000-829-178 N-(2-Hydroxyethyl)nicotinamide nitrate N-(2-Hydroxyethyl)nicotinamide nitrate (ester) N-[2-(Nitrooxy)ethyl]pyridine-3-carboxamide N0837 NCGC00025357-01 NCGC00025357-02 NICORANDIL Nicorandil (JP15/USAN/INN) Nicorandil Aventis Brand Nicorandil Merck Brand Nicorandil [USAN:BAN:INN:JAN] Nicorandilum Nicorandilum [INN-Latin] Nitrate, 2-Nicotinamidethyl Nitrate, 2-Nicotinamidoethyl RP-46417 Rhone Poulenc Rorer Brand of Nicorandil Rhone-Poulenc Rorer Brand of Nicorandil S1971_Selleck SAM001246701 SG 75 SG-75 SG75 SMR000466365 Sigmart Sigmart (TN) TL8004616 Tocris-2147 ZINC01533102 | |
| | 38 | | Fexofenadine | approved | Phase 4 | 63 | 83799-24-0 | 3348 | 159389-12-5 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid 76815-58-2 83799-24-0 AC1L1FQB Allegra Allegra-D 12 Hour Allegra-D 24 Hour BRD-A73368467-003-02-8 BSPBio_003521 C06999 C32H39NO4 CHEBI:5050 CHEMBL914 CID3348 Carboxyterfenadine D07958 DB00950 EU-0100488 F 9427 Fexofenadine Fexofenadine (INN) Fexofenadine [INN:BAN] Fexofenadine hydrochloride Fexofendine HSDB 7486 KBio2_002449 | KBio2_005017 KBio2_007585 KBio3_002742 KBioGR_000807 KBioSS_002456 L000869 LS-28827 Lopac0_000488 MDL 16455 MolPort-002-508-207 NCGC00015453-03 NCGC00015453-06 NCGC00092389-02 NCGC00092389-03 SPBio_001197 STK624102 STOCK6S-26154 Spectrum2_001179 Spectrum3_001921 Spectrum4_000204 Spectrum5_001474 Spectrum_001914 Telfast Telfast (TN) Terfenadine acid metabolite Terfenadine carboxylate Terfenadine-COOH Terfenidine carboxylate, MDL 16455 UNII-E6582LOH6V fexofenadine | |
| | 39 | | Cetirizine | approved | Phase 4 | 135 | 83881-51-0 | 2678 | (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid (2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid 83881-51-0 83881-52-1 (di-hydrochloride) AC-5545 AC1L1E7T AC1Q768B AKOS003589059 BPBio1_000469 BRD-A42571354-300-05-4 BSPBio_000425 BSPBio_002302 Benaday C07778 C21H25ClN2O3 CHEBI:3561 CHEMBL1000 CID2678 CPD001453715 Cetiderm Cetiderm (TN) Cetirizin Cetirizina Cetirizina [Spanish] Cetirizine (INN) Cetirizine [INN:BAN] Cetirizine hydrochloride Cetirizinum Cetirizinum [Latin] Cetrizine Hcl Cetryn | D07662 DB00341 HMS1539O07 Hitrizin Film Tablet Humex I06-0454 L000655 LS-11409 MLS002222268 MolPort-002-506-309 NCGC00167781-01 NCGC00167781-02 NCGC00167781-03 NCGC00167781-04 P-071 Prestwick0_000503 Prestwick1_000503 Prestwick2_000503 Prestwick3_000503 Reactine SAM002589989 SMR000145214 SPBio_002346 STK711108 STOCK2S-03020 Setir TimTec1_002075 UNII-YO7261ME24 Virlix Ziptek Zirtek Zyrlex Zyrtec [(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid cetirizine nchembio714-comp3 |
| | 40 | | Nitrous oxide | approved, vet_approved | Phase 4 | 181 | 10024-97-2 | 948 | 00583_FLUKA 10024-97-2 126386-65-0 129451-49-6 130835-71-1 147527-07-9 175876-44-5 295590_ALDRICH 794457-85-5 847968-13-2 850203-00-8 AC1L1ADZ C00887 CCRIS 1225 CHEBI:17045 CHEMBL1234579 CID948 D00102 D009609 Diazyne 1-oxide Dinitrogen monoxide Dinitrogen oxide Distickstoffmonoxid E942 EINECS 233-032-0 FEMA 2779 FEMA No. 2779 Factitious air Gas, Laughing Gas, laughing Gaz hilarant HSDB 504 Hyponitrous acid anhydride LS-7622 Lachgas Laughing gas N2O NITROUS-OXIDE NNO | Nitral Nitrious oxide Nitrogen hypoxide Nitrogen monoxide Nitrogen oxide (N2O) Nitrogen protoxide Nitrogenium oxydulatum Nitrous oxide Nitrous oxide (JP15/USP) Nitrous oxide (TN) Nitrous oxide [Anaesthetics, volatile] Nitrous oxide [JAN] Nitrous oxide [UN1070] [Nonflammable gas] Nitrous oxide [UN1070] [Nonflammable gas] Nitrous oxide [anaesthetics, volatile] Nitrous oxide [jan] Nitrous oxide, JAN, USAN Nitrous oxide, compressed Nitrous oxide, refrigerated liquid Nitrous oxide, refrigerated liquid [UN2201] [Nonflammable gas] Nitrous oxide, refrigerated liquid [UN2201] [Nonflammable gas] Nitrous-oxide Oxide, Nitrous Oxide, nitrous Oxido nitroso Oxido nitroso [Spanish] Oxidodinitrogen(N--N) Oxyde nitreux Protoxyde d'azote [French] Stickdioxyd Stickdioxyd [German] Stickstoff(I)-oxid UN1070 UN2201 gaz hilarant nitrogenium oxydulatum nitrous oxide oxidodinitrogen(N--N) oxyde nitreux protoxyde d'azote | |
| | 41 | | Ranibizumab | approved | Phase 4 | 486 | 347396-82-1 | 459903 | 347396-82-1 D05697 Lucentis Lucentis (TN) | Ranibizumab Ranibizumab (USAN/INN) Ranibizumab (genetical recombination) Ranibizumab (genetical recombination) (JAN) ranibizumab rhuFab V2 |
| | 42 | | Everolimus | approved | Phase 4, Phase 1 | 1940 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 43 | | Sirolimus | approved, investigational | Phase 4, Phase 1 | 1940 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 44 | | Remifentanil | approved | Phase 4 | 471 | 132875-61-7 | 60815 | 1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester 132539-07-2 (mono-hydrochloride) 132875-61-7 3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester 4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester AC1L1TZ8 AC1Q5ZGR BIDD:GT0029 C08021 CHEBI:8802 CHEMBL1005 CID60815 D08473 DB00899 | DEA No. 9739 GI 87084B GI 87084X GI87084B L001266 LS-115982 MolPort-004-286-006 REMIFENTANIL Remifentanil (INN) Remifentanil [INN:BAN] Remifentanyl UNII-P10582JYYK Ultiva Ultiva (TN) methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate | |
| | 45 | | Midazolam | approved, illicit | Phase 4, Phase 2, Phase 3 | 723 | 59467-70-8 | 4192 | 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate 59467-70-8 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride 8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine AC-18749 AC1L1HMA BIDD:GT0647 BRN 0625572 Buccolam C07524 C18H13ClFN3 CHEMBL655 CID4192 D00550 DB00683 DEA No. 2884 Dazolam Dea No. 2884 | Dormicum Dormicum (TN) EINECS 261-774-5 LS-77780 Midanium Midazolam Midazolam (JAN/INN) Midazolam Base Midazolam Hcl Midazolam [INN:BAN:JAN] Midazolamum Midazolamum [INN-Latin] Midosed MolPort-003-849-219 NCGC00168254-01 Ro 21-3981 TL8003787 UC429_SIGMA UNII-R60L0SM5BC Versed ZINC00001732 midazolam nchembio747-comp32 |
| | 46 | | Meperidine | approved | Phase 4, Phase 2 | 75 | 57-42-1 | 4058 | 1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German] 1-Methyl-4-phenylisonipecotic acid, ethyl ester 1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester 4-Carbethoxy-1-methyl-4-phenylpiperidine 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester 50-13-5 (hydrochloride) 57-42-1 610593_ALDRICH 610593_FLUKA AC1L1HBJ C07128 CHEBI:122528 CHEMBL607 CID4058 D008614 D08343 DB00454 DEA No. 9230 Demarol Demerol DivK1c_000983 Dolcontral Dolosal Dolsin EINECS 200-329-1 Ethyl 1-methyl-4-phenylisonipecotate Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate HSDB 3116 IDI1_000983 Isonipecain Isonipecaine Isonipecaïne Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester KBio1_000983 | L000908 LS-85121 Lidol Lydol Meperidine Meperidine solution Meperidol Methyl phenylpiperidine carbonic acid ethyl ester MolPort-001-785-564 N-Methyl-4-phenyl-4-carbethoxypiperidine NINDS_000983 Nemerol Operidine EPJ I Operidine EPJ-I Pethanol Pethidin Pethidine Pethidine (INN) Pethidine DBL Pethidine DBL (TN) Pethidine dbl Pethidineter Pethidinum Pethidinum [INN-Latin] Petidina Petidina [INN-Spanish] Petydyna Petydyna [Polish] Phetidine Piperosal Pipersal Péthidine Sauteralgyl Spasmedal Spasmodolin UNII-9E338QE28F YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI) meperidine |
| | 47 | | Bupivacaine | approved, investigational | Phase 4 | 1233 | 2180-92-9, 38396-39-3 | 2474 | ( inverted exclamation markA)-bupivacaine (+-)-Bupivacaine (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (RS)-bupivacaine (±)-bupivacaine 1-Butyl-2',6'-pipecoloxylidide 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 15233-43-9 2180-92-9 38396-39-3 AB00053674 AC-2096 AC1L1DRE AC1Q5LX4 AH 250 AKOS001637202 AR-1A0242 Anekain BPBio1_000298 BRD-A01636364-003-05-2 BSPBio_000270 BSPBio_002607 Bio-0886 Bloqueina Bucaine Bucaine (TN) Bupivacaina Bupivacaina [INN-Spanish] Bupivacaine (INN) Bupivacaine Carbonate Bupivacaine HCL Bupivacaine HCL KIT Bupivacaine Monohydrochloride, Monohydrate Bupivacaine [INN:BAN] Bupivacainum Bupivacainum [INN-Latin] Bupivan C07529 C18H28N2O CBupivacaine CHEBI:3215 CHEMBL1098 CID2474 Carbostesin D07552 DB00297 DL-Bupivacaine DUR-843 | DepoBupivacaine DivK1c_000758 EINECS 218-553-3 EINECS 253-911-2 HMS2090F12 IDI1_000758 KBio1_000758 KBio2_002004 KBio2_004572 KBio2_007140 KBio3_001827 KBioGR_001516 KBioSS_002004 KST-1A4609 L000695 LAC-43 LS-109841 LS-2222 MLS001361336 Marcaina Marcaine Marcaine HCL Marcaine Spinal MolPort-004-955-820 NCGC00178579-01 NCGC00178579-02 NINDS_000758 NSC119660 Prestwick0_000305 Prestwick1_000305 Prestwick2_000305 Prestwick3_000305 SMR000058218 SPBio_001558 SPBio_002489 Sensorcaine Sensorcaine-MPF Sensorcaine-MPF Spinal Spectrum2_001589 Spectrum3_000974 Spectrum4_001098 Spectrum5_001483 Spectrum_001524 Transdur-Bupivacaine UNII-Y8335394RO Win 11318 Win 11318 HCl bupivacaine cBupivacaine dl-1-Butyl-2',6'-pipecoloxylidide racemic bupivacaine |
| | 48 | | Ketamine | approved, vet_approved | Phase 4 | 569 | 6740-88-1 | 3821 | (+-)-Ketamine (+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone (+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone (+/-)-Ketamine (-)-Ketamine (S)-(-)-Ketamine (S)-Ketamine (±)-ketamine 100477-72-3 2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one 2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone 2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone 2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone 2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone 33643-45-7 6740-88-1 79499-51-7 AC1L1GSH AC1Q40UR AKOS001053247 BRN 2216965 C07525 C13H16ClNO CHEBI:138833 CHEBI:6121 CHEMBL742 CI 581 base CI-581 CID3821 CLSTA 20 Calypsol Cetamina Cetamina [INN-Spanish] Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI) Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI) Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI) D08098 DB01221 | DEA No. 7285 DL-ketamine DivK1c_000217 EINECS 229-804-1 Esketamine Green IDI1_000217 KBio1_000217 KETAMINE HCL Ketaject Ketalar Ketalar base Ketamina Ketamine (INN) Ketamine Base Ketamine HCL Ketamine [INN:BAN] Ketaminum Ketaminum [INN-Latin] Ketanest Ketoject Ketolar Kétamine L-Ketamine LS-57301 MLS001331674 MolPort-001-838-070 NCGC00159480-02 NCGC00159480-03 NINDS_000217 NMDA NSC 70151 NSC70151 SMR000238141 Special K Special K [street name] T385 Tekam Tekam (TN) UNII-690G0D6V8H dl-Ketamine ketamine l-Ketamine |
| | 49 | | Histamine | approved, investigational | Phase 4, Phase 2 | 1050 | 75614-87-8, 51-45-6 | 774 | .beta.-Imidazolyl-4-ethylamine 1H-Imidazole-4-ethanamine 1H-Imidazole-5-ethanamine 1avn 1qft 2-(1H-Imidazol-4-yl)ethanamine 2-(1H-Imidazol-4-yl)ethylamine 2-(1H-Imidazol-5-yl)ethanamine 2-(1H-Imidazol-5-yl)ethylamine 2-(1H-imidazol-4-yl)ethan-1-amine 2-(1H-imidazol-5-yl)ethanamine 2-(3H-Imidazol-4-yl)-ethylamine 2-(4-Imidazolyl)ethanamine 2-(4-Imidazolyl)ethylamine 2-(4-imidazolyl)ethylamine 2-Imidazol-4-yl-Ethylamine 2-Imidazol-4-ylethylamine 2-[4-Imidazolyl]ethylamine 4-(2-Aminoethyl)-1H-imidazole 4-(2-Aminoethyl)imidazole 4-Imidazoleethylamine 4-imidazoleethylamine 5-Imidazoleethylamine 5-imidazoleethylamine 51-45-6 53290_FLUKA 64422-25-9 924364-91-0 AC-13185 AC1L19ZT AC1Q54BV AC1Q54BW AKOS000274386 ALBB-005968 BCBcMAP01_000250 BSPBio_001117 BSPBio_002124 Bio1_000487 Bio1_000976 Bio1_001465 Bio2_000389 Bio2_000869 C00388 CCRIS 6535 CHEBI:18295 CHEMBL90 CID774 D08040 DivK1c_000308 EINECS 200-100-6 Eramin Ergamine Ergotidine F411C768-A159-4FC0-A195-291A08BB03AA Free histamine H7125_SIGMA HMS1362G19 HMS1792G19 HMS1990G19 HSDB 3338 HSM Histamine Histamine (DCF) Histamine Base Histamine [USAN] Histamine, Free Base Histaminum | Histaminum (TN) IDI1_000308 IDI1_002144 Imidazole-4-ethylamine Istamina Istamina [Italian] KBio1_000308 KBio2_000457 KBio2_001325 KBio2_003025 KBio2_003893 KBio2_005593 KBio2_006461 KBio3_000853 KBio3_000854 KBio3_001344 KBioGR_000457 KBioGR_001580 KBioSS_000457 KBioSS_001325 L-Histamin base L-Histamine L-histamine L000292 LS-75835 Lopac-H-7250 Lopac0_000595 MLS000069447 MolPort-001-785-597 MolPort-002-042-264 NCGC00015513-01 NCGC00015513-08 NCGC00093371-02 NCGC00093371-03 NCGC00093371-04 NCGC00093371-05 NINDS_000308 NSC 33792 NSC33792 SDCCGMLS-0066601.P001 SMP1_000151 SMR000059091 SPBio_000729 ST073926 STK346752 STOCK5S-55669 Spectrum2_000665 Spectrum3_000452 Spectrum4_000960 Spectrum5_000796 Spectrum_000845 Theramine UNII-820484N8I3 WLN: T5M CNJ D2Z ZERO/004089 [3H]histamine b-Imidazolyl-4-ethylamine beta-Aminoethylglyoxaline beta-Aminoethylimidazole beta-Aminothethylglyoxaline beta-Imidazolyl-4-ethylamine beta-aminoethylglyoxaline beta-aminoethylimidazole beta-aminothethylglyoxaline bmse000744 histamine nchembio.87-comp54 nchembio714-comp1 | |
| | 50 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 1 | 3706 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
|
Interventional clinical trials: (show top 50)
(show all 1066)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia | Unknown status | NCT01449253 | Phase 4 | | 2 | Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery | Unknown status | NCT02133638 | Phase 4 | | 3 | Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillectomy in Children | Unknown status | NCT02205580 | Phase 4 | | 4 | Sodium Bicarbonate in Cardiopulmonary Resuscitation | Unknown status | NCT01377337 | Phase 4 | | 5 | Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage | Unknown status | NCT01180192 | Phase 4 | | 6 | Home Oxygen Therapy in Bronchiolitis | Unknown status | NCT01216553 | Phase 4 | | 7 | Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome | Unknown status | NCT00560586 | Phase 4 | | 8 | The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia | Unknown status | NCT01083784 | Phase 4 | | 9 | Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study | Unknown status | NCT01361373 | Phase 4 | | 10 | Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics | Unknown status | NCT00845936 | Phase 4 | | 11 | AZ, MZ, and the Pulmonary System Response to Hypoxia | Completed | NCT02760121 | Phase 4 | | 12 | Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers | Completed | NCT01873612 | Phase 4 | | 13 | Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation | Completed | NCT01692821 | Phase 4 | | 14 | 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females | Completed | NCT02356107 | Phase 4 | | 15 | Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy | Completed | NCT02628106 | Phase 4 | | 16 | Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure | Completed | NCT00517725 | Phase 4 | | 17 | Ambulatory Oxygen Effects on Muscles in COPD | Completed | NCT01722370 | Phase 4 | | 18 | Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects. | Completed | NCT00924833 | Phase 4 | | 19 | Single High Dose Vitamin C, E in Severe Birth Asphyxia | Completed | NCT01743742 | Phase 4 | | 20 | CPAP in SAHS Patients With Hypertension | Completed | NCT02398032 | Phase 4 | | 21 | Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate | Completed | NCT00880672 | Phase 4 | | 22 | Doxapram as an Additive to Propofol Sedation in Sedation for ERCP | Completed | NCT02171910 | Phase 4 | | 23 | Safety Study of Analgesia After Craniotomy Surgery With End Tidal (ET) Carbon Dioxide (CO2) Monitoring | Completed | NCT01327677 | Phase 4 | | 24 | Etomidate vs. Midazolam for Sedation During ERCP | Completed | NCT02027311 | Phase 4 | | 25 | Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation | Completed | NCT01260662 | Phase 4 | | 26 | Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude | Completed | NCT00714740 | Phase 4 | | 27 | The Effect of Nasal Cannula During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy | Completed | NCT01725464 | Phase 4 | | 28 | Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea Before and After Treatment With CPAP. | Completed | NCT00360659 | Phase 4 | | 29 | The Use of Statins for Myocardial Death Prevention | Completed | NCT00772564 | Phase 4 | | 30 | Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study) | Completed | NCT01103336 | Phase 4 | | 31 | Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude | Completed | NCT02024386 | Phase 4 | | 32 | Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition | Completed | NCT01545479 | Phase 4 | | 33 | Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls. | Completed | NCT00291993 | Phase 4 | | 34 | Ranibizumab in Patients With Branch Retinal Vein Occlusion | Completed | NCT01027481 | Phase 4 | | 35 | The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia | Completed | NCT01091571 | Phase 4 | | 36 | The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis | Completed | NCT01507766 | Phase 4 | | 37 | Erythropoietin in the Prevention of Acute Mountain Sickness | Completed | NCT01665781 | Phase 4 | | 38 | Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients | Completed | NCT01996124 | Phase 4 | | 39 | Bispectral Index and Clinical Parameters Evaluation in Dental Procedures | Completed | NCT02671578 | Phase 4 | | 40 | Investigating the Accuracy of the Home Glucose Monitors in Hypoglycemia | Completed | NCT01013402 | Phase 4 | | 41 | Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics | Completed | NCT02363920 | Phase 4 | | 42 | Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel | Completed | NCT00637455 | Phase 4 | | 43 | Propofol-Ketamine vs Remifentanyl-Ketamine for Sedation in Pediatric Patients Undergoing Colonoscopy | Completed | NCT02602743 | Phase 4 | | 44 | Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth | Completed | NCT00120588 | Phase 4 | | 45 | Helmet Ventilation in Acute Hypercapnic Respiratory Failure | Completed | NCT01645358 | Phase 4 | | 46 | Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients | Completed | NCT00804349 | Phase 4 | | 47 | Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD) | Completed | NCT00491803 | Phase 4 | | 48 | Inhaled Nitric Oxide by Oxygen Hood in Neonates | Completed | NCT00732537 | Phase 4 | | 49 | Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management | Completed | NCT01710891 | Phase 4 | | 50 | Treatment of High Altitude Polycythemia by Acetazolamide | Completed | NCT00424970 | Phase 4 |
|
